Organogenesis
ORGO
NASDAQ
IPO2016
about ORGO
Organogenesis is a biotechnology company focused on developing advanced therapies for tissue repair and regeneration, including engineered skin substitutes and biologics to address unmet medical needs in wound care and burns.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $5.11 | $6.20 | $4.99 | $493.48M | 33.04M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.10 | n/a | 7.35 | -12.45% | -9.30% | 0% |